 | Janssen COVID-19 vaccine (redirect from Ad26.COV2.S) Janssen Ad26.COV2.S (COVID-19) vaccine (Guidance). World Health Organization. 15 June 2021. WHO/2019-nCoV/vaccines/SAGE_recommendation/Ad26.COV2.S/2021.2... 142 KB (11,316 words) - 14:22, 4 February 2024 |
S. destroyer tender Search for "ad26" or "ad-26" on Wikipedia. 26 Air Defence Regiment (India) (26.AD) Ad26.COV2.S, COVID-19 vaccine by Janssen Pharmaceutical... 629 bytes (122 words) - 22:44, 11 July 2021 |
known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S protein... 318 KB (19,351 words) - 20:00, 21 April 2024 |
 | With the increasing prevalence of adenoviral vaccines, two vaccines, Ad26.COV2.S and ChadOx1-nCoV-19, have been linked to the rare clotting disorder,... 32 KB (3,317 words) - 14:21, 24 January 2024 |
 | The South African Health Products Regulatory Authority (SAHPRA) is the organisation in charge of regulating the use of all Health Products throughout the... 7 KB (567 words) - 12:25, 27 September 2023 |
 | similar to other viral vector vaccines like AZD1222, Gam-COVID-Vac, and Ad26.COV2.S. Its single-dose regimen and normal refrigerator storage requirement... 36 KB (3,379 words) - 00:52, 31 December 2023 |
Study of Ad26.COV2.S in Adults". 4 August 2020. Archived from the original on 16 September 2020. Retrieved 23 August 2020. "A Study of Ad26.COV2.S for the... 192 KB (22,021 words) - 19:29, 15 April 2024 |
 | granted a provisional determination in relation to its COVID‑19 vaccine, Ad26.COV2.S, in November 2020. On 24 January 2021, the TGA granted provisional approval... 122 KB (11,028 words) - 02:32, 27 January 2024 |
 | trials. In January, Johnson & Johnson, which held trials for its Janssen (Ad26.COV2.S) vaccine in South Africa, reported the level of protection against moderate... 72 KB (6,070 words) - 06:39, 3 February 2024 |
 | Operation Warp Speed (category U.S. federal government response to the COVID-19 pandemic) Operation Warp Speed used BARDA as the financial interface between the U.S. federal government and the biomedical industry. The program was initially... 71 KB (5,902 words) - 12:57, 30 April 2024 |